A Study In Patients With Type 2 Diabetes Mellitus

Completed · Phase 3

Conditions studied: Diabetes Mellitus, Type 2

In brief

This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.

Key facts

Study ID

NCT00256867

Run by

GlaxoSmithKline

People needed

369

Starts

2005-08-18

Expected to finish

2006-10-31

Last updated by the study team

2018-07-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A clinical diagnosis type 2 diabetes mellitus.
• Women must not be pregnant or breastfeeding during the study and 30 days after the study.
• Must sign an informed consent form at the study clinic.

You may not qualify if…

• Severe chronic diseases that would prevent from participating and completing the study by investigator's judgement.
• Use of an investigational drug within 30 days or 5 half lives before first dose of study medication.
• Insulin use for > 1 week in past 3 months.

Where it is running

• GSK Investigational Site — Fresno, California, United States
• GSK Investigational Site — Wheat Ridge, Colorado, United States
• GSK Investigational Site — Waterbury, Connecticut, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Saint Cloud, Florida, United States
• GSK Investigational Site — Atlanta, Georgia, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Melrose Park, Illinois, United States
• GSK Investigational Site — Springfield, Illinois, United States
• GSK Investigational Site — Avon, Indiana, United States
• GSK Investigational Site — Elkhart, Indiana, United States
• GSK Investigational Site — Sunset, Louisiana, United States
• GSK Investigational Site — Waltham, Massachusetts, United States
• GSK Investigational Site — City of Saint Peters, Missouri, United States
• GSK Investigational Site — Billings, Montana, United States
• GSK Investigational Site — Las Vegas, Nevada, United States
• GSK Investigational Site — Jamaica, New York, United States
• GSK Investigational Site — Rochester, New York, United States
• GSK Investigational Site — Columbus, Ohio, United States
• GSK Investigational Site — Bend, Oregon, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Tualatin, Oregon, United States
• GSK Investigational Site — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.